Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Sherif Gonem Rachid Berair Vijay Mistry Chris Brightling Adel H Mansur Michelle Bourne Andrew Wardlaw Amisha Singapuri Ian D. Pavord Ruth Hartley Björn Holzhauer Salman H Siddiqui |
| Publication date | August 5, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |